RNA interference with zilebesiran is effective for mild to moderate hypertension

Hypertension is a significant global health concern, contributing to cardiovascular mortality and the progression of kidney…

Intravenous ertapenem therapy is effective and durable for recalcitrant hidradenitis suppurativa

In a recent study published in JAMA Dermatology, researchers revealed a breakthrough treatment for recalcitrant hidradenitis…

Gepotidacin excels in clinical trials, outperforming nitrofurantoin as a promising UTI treatment

A team of medical researchers has unveiled promising results from two Phase III non-inferiority clinical trials…

Research shows the efficacy of peptide receptor radionuclide therapy in treating metastatic insulinomas

A novel study published in The Journal of Nuclear Medicine has revealed the promising effectiveness of…

New heparanase inhibitors protect endothelial glycocalyx, preventing diabetic eye and kidney disease

Over 8% of the global adult population is affected by diabetes mellitus, which frequently leads to…

SARS-CoV-2 fragments increases inflammation by mimicking immune system peptides

Researchers have conducted an innovative study on the inflammatory capacity of fragmented components of the severe…

Researchers identify potential treatment target for CDKL5 deficiency disorder

DKL5 deficiency disorder (CDD) arises from pathogenic variants in the CDKL5 gene, leading to severe developmental…

Human papillomavirus infection and its alarming link to cardiovascular mortality in women

Cardiovascular diseases (CVDs) remain a global health concern, claiming an estimated 17.9 million lives (32% of…

Xist ribonucleoproteins contribute to female gender- based autoimmunity

According to a recent study published in the journal Cell, the Xist ribonucleoprotein complex has a…

Extended SARS-CoV-2 infection and distinct mutations observed in immunocompromised individuals

Immunocompromised individuals, notably those with conditions like autoimmune deficiency syndrome (AIDS), exhibit increased susceptibility to SARS-CoV-2…

Don’t miss our updates!

We don’t spam! Read our [link]privacy policy[/link] for more info.